Price as of close on Nov 3, 2026 · Financials updated Oct 9, 2026
Basics
Sector
Basic Materials
Industry
Specialty Chemicals
Country
United States
Market cap
616.5M USD
Enterprise value
1.6B USD
Full-time employees
5,000
Overall health
Strength:its shares are priced lower than most peers relative to what it earnspriced lower than peers for its earnings
Drawback:higher risk than most peers: more debt relative to equity (2.15× vs a peer median of 0.36×)higher risk: more debt vs equity (2.15× vs peers 0.36×)
About average: profitability
Ranks #471 of 1,217 basic materials companies (top 39%)
Much more borrowing than peers.Debt is 2.1× equity vs a peer median of 0.4×.Debt is 2.1× equity vs peers 0.4×.
Debt is 2.1× shareholders' equity, against a peer median of 0.4×, among the highest 10% of its peer group.Debt is 2.1× shareholders' equity, vs peers 0.4×, among the highest 10% of its peer group.
Earnings turned from a loss to a profit. Profit per share this year after a loss last year.
Mativ made a profit per share in its latest year after a loss the year before.
Profit is backed by cash. Free cash flow is 143% of reported profit.
Mativ's free cash flow is 143% of its reported profit, so its earnings are turning into cash it can reinvest, pay out or use to reduce debt.
Why it changed since the Oct 27, 2026 close: Score 81 → 82
Peer companies moved+1
Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.
Why it changed since the Oct 27, 2026 close: Safety percentile 7 → 8
Peer companies moved+1
Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about Mativ
Is Mativ getting weaker?
Its latest SEC filing (Aug 6, 2026) showed no major changes. Its overall score is unchanged at 57/100 since Oct 28, 2026.
How is Mativ valued vs its peers?
Priced lower than most peers relative to what it earns. Valuation scores 94/100 against 1,371 basic materials peers.Earnings yield 14.5% vs a peer median of 3.6% (stronger than 95% of peers).Earnings yield 14.5% vs peers 3.6% (stronger than 95% of peers).
Is Mativ growing?
Yes, faster than most of its peers. Growth scores 82/100 against 1,371 basic materials peers.
How profitable is Mativ?
About as profitable as its peers. Profitability scores 44/100 against 1,371 basic materials peers.Return on assets 4.5% vs a peer median of 2.5% (stronger than 69% of peers).Return on assets 4.5% vs peers 2.5% (stronger than 69% of peers).Operating margin 3.5% vs a peer median of 7.6% (weaker than 68% of peers).Operating margin 3.5% vs peers 7.6% (weaker than 68% of peers).
How risky is Mativ?
Higher risk relative to 1,371 basic materials peers, judged on debt, liquidity and share-price swings.Debt / equity 2.15× vs a peer median of 0.36× (weaker than 100% of peers).Debt / equity 2.15× vs peers 0.36× (weaker than 100% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Quarter ended Jun 30, 2026 · filed Aug 6, 2026 · compared with the quarter ended Mar 31, 2026
No major changes
Previous quarter
Latest quarter
Change
Revenue (12 months)
2.0B USD
2.0B USD
+0.3%
Net income (12 months)
76.4M USD
89.5M USD
+17.1%
Operating margin
2.7%
3.5%
+0.8 pts
Free cash flow (12 months)
116.2M USD
127.7M USD
+9.9%
Debt
1.0B USD
1.0B USD
−3.7%
Cash
82.3M USD
66.3M USD
−19.4%
Shares outstanding
55.1M
55.2M
+0.1%
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Industry valuation context
Industry: Specialty Chemicals · 32 companies
Valuations in Specialty Chemicals are above their usual range since 2016.
74% of months since 2016 were valued lower than now.
17% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values −8% and earnings +13% (medians): earnings grew faster than prices.
Median price-to-sales is −36% vs the whole market, against a usual −31%.
2016Shaded: most expensive fifth of its range2026
This is a cyclical group: after a downturn, trailing earnings and sales fall faster than prices, which can make valuations look high near a cycle's low.
Describes valuations since 2016; it does not predict prices. US companies worth $1B+, from SEC filings and month-end prices, as of Aug 2026. Today's companies and industry labels are used throughout. Measured on earnings, EBITDA, sales and free cash flow yields. How this works
Financials
Fiscal years from SEC annual filings · change vs the prior year
Key ratios
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Change
Gross margin
19.7%
18.7%
17.6%
18.4%
18.3%
▼ 0.1 pts
Operating margin
-1.7%
-2.5%
-20.4%
0.3%
-19.3%
▼ 20 pts
Net margin
9.6%
-0.4%
-15.3%
-2.5%
-17.0%
▼ 15 pts
Return on assets (ROA)
3.7%
-0.2%
-11.7%
-2.0%
-16.4%
▼ 14 pts
Return on equity (ROE)
13.0%
-0.6%
-32.6%
-5.7%
-67.7%
▼ 62 pts
Free cash flow margin
4.1%
9.6%
2.0%
2.0%
4.7%
▲ 2.7 pts
Current ratio
2.57×
2.09×
2.53×
2.40×
2.24×
▼ 6.6%
Quick ratio
1.45×
1.20×
1.28×
1.10×
1.08×
▼ 1.7%
Debt to equity
1.89×
1.46×
1.19×
1.30×
2.07×
▲ 60%
Interest coverage
-0.40×
-0.70×
-6.65×
0.08×
-5.41×
▼ >999%
MATV price history
Price history is added with the daily price update and will appear after the next one.